Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy. - Belgiovine C; Frapolli R; Liguori M; Digifico E; Colombo FS; Meroni M; Allavena P; D'Incalci M (European journal of immunology, 2021)